Replies to post #127742 on Savvy Trades and Investments

[wadegarret]

R59- JAZZ

What do you think of this one, after the blockbuster phase 3 results for Ziihera ? The only major drug competitor I know of is Roche's Vyloy, and that drug has way more serious side effects that caused 20% to discontinue vs 2.5% for Ziihera.

[hweb2]

Yikes that was one ugly market reversal today. How much would the markets have been down on a bad report from NVDA??